The present invention relates to a non-radioactive, heavy-atom isotopologue of Compound 1 containing one or more deuterium in place of a hydrogen covalently bound to carbon. The Compound 1 isotopologues of the invention are inhibitors of norepinephrine uptake and possess unique biopharmaceutical and pharmacokinetic properties compared to the corresponding non-isotope containing compounds. They may also be used to accurately determine the concentration of Compound 1 in biological fluids. The invention further provides compositions comprising these heavy-atom Compound 1 isotopologue and methods of treating diseases and conditions linked to reduced neurotransmission of norepinephrine.
Source: Patent WO2007005643A2 – Novel aryloxyphenylpropanamines – Google Patents
Video Search
[tubepress output=”searchInput” searchResultsUrl=”https://search.excitingads.com/search-results-dailymotion/”]
[tubepress mode=”dailymotionTag” dailymotionTagValue=’Novel’]
tubepress enableQuickplay=”true” theme=”tubepress/legacy-quickplay” playerLocation=”popup” autoPlay=”false” thumbHeight=”514″ thumbWidth=”625″ responsiveEmbeds=”false” paginationBelow=”false”]
Video Search
[tubepress output=”searchInput” searchResultsUrl=”https://search.excitingads.com/search-results-dailymotion/”]
